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Abstract 
As a result of the chain of transformations from 1,3-butanedione with aryl and methoxy sub-
stituents through nitrosation and cyclization with hydrazine, the corresponding nitrosopyrazoles and 
aminopyrazoles were synthesized. According to this scheme, eight new previously unknown com-
pounds were obtained. Their structures were established by the methods of IR, UV, 1H NMR, 13C 
NMR spectroscopy and mass spectrometry. DFT method of quantum-chemical calculations showed 
that obtained aminopyrazoles can exist as two tautomers; it was also confirmed by NMR 1H spec-
troscopy data. In the case of acylation, an isomer is formed, where aryl substituent takes place in the 
fifth, rather than in the third position of the pyrazole ring, as shown by the DFT calculations. 
 
Keywords: nitrosopyrazoles, aminopyrazoles, acylation, tautomerism. 
 
1. Introduction 
It is known that many pyrazole derivatives exhibit different types of biological activity [1-
10]. However, thousands of substances are synthesized or obtained from natural raw materials, but 
only some of them are ultimately effective in the creation of medicines [11]. The reasons of that are 
still unclear, because the strong theory, connecting the structure of mentioned compounds with their 
pharmaceutical properties, does not exist. Therefore, it seems important to obtain new previously 
unknown compounds, including new pyrazole derivatives, which can exhibit biological activity. We 
need more amount of experimental information to establish correlation between structure of these 
compounds and their potential properties and use. 
In the present work we obtained aminopyrazoles with aryl and methoxymethyl substituents 
and investigated the reaction of their acylation. This direction of synthesis was chosen due to the 
fact that presence of pharmacophore amino or acetamide groups in the molecule provides the ap-
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pearance of any biological activity. Modification of molecule by a polar methoxymethyl group 
changes the polarity of the whole molecule, which leads to an increase in the activity [12]. 
There are also some results, presented early, indicating an importance of methoxy group 
presence for biological activity of molecules. For example, it ensures that the necessary conforma-
tions of (methoxypropyl)thiazole are adopted for successful binding to the 5-lipoxygenase enzyme 
[13]. A methoxy derivative of 2-hydroxymethyl estradiol (namely 2-methoxymethyl estradiol) is 
more effective, than its natural analog, as tubulin-binding substance killing cancerous cells by in-
hibiting microtubule dynamics [14]. 3-Methoxymethyl cephem derivatives showed good activity 
against a wide variety of bacteria including some β-lactamase producing species [15]. It was shown 
also that omitting of the (methoxymethyl)methinoxy moiety of the benzodioxanyl group considera-
bly decreases haedoxan insecticidal activity [16]. 
At the same time, arylation is an interesting approach that can accomplish structural modifi-
cations of molecules with the goal of synthesizing new substances with biological activities [17]. 
For example, some of the combined molecules including the indole and 2-naphthol skeletons dem-
onstrated strong antioxidant and antibacterial properties [18]. Arylation of quinolin-4-ylinidazoline 
leads to creation of compounds with a broad-spectrum antimicrobial activity, in particular, an-
tiplasmodial and antimycobacterial [19]. Thereby both methoxymethyl and aryl groups are the sub-
stituents, which can vary or even enhance biological activity of other molecules, including pyrazole. 
Earlier, we reported the synthesis of new derivatives of alkoxymethylnitrosopyrazoles [20], 
their reduction to aminopyrazoles [21] and their acylation [22]. The present work is devoted to the 
preparation of previously unknown 4-nitroso-1H-pyrazole derivative with methoxymethyl and 2-
naphthyl substituents, its reduction to amine with further acylation by acetic anhydride or 
chloroacetyl chloride. 
 
2. Experimental 
2.1. Synthesis 
2.1.1. (2a) 4-Methoxy-1-(naphthalen-2-yl)butane-1,2,3-trione-2-oxime 
5 g (20.7 mmol) of diketone 1a in acetic acid were dissolved and cooled to 12 °C. Sodium 
nitrite weighing 1.57 g (22.8 mmol) was added in portions over an hour so that T ≤ 15° C. The reac-
tion mixture was diluted with water and extracted with ether. The extract was evaporated. As a re-
sult, white precipitate was formed. Yield 4.95 g (88.24%), white crystals, m.p. 169-170 °C. IR spec-
trum (thin layer), ν, cm−1: 1672 (CH2C=O), 1695 (naphthyl-C=O). Mass spectrum, m/z (I, %): 271 
(13) [M]+, 239 (12), 155 (100), 127 (75), 45 (54). NMR Spectrum (1H, δ, ppm): 3.32 (3H, CH3), 
4.8 s (2H, CH2O), 7.61-8.42 m (7H naphthyl), 13.29 s (1H, NH). NMR spectrum 
13C, δ, ppm: 
58.96, 73.43, 122.84, 127.68, 128.16, 129.41, 129.92, 130.05, 131.87, 132.47, 132.55, 136.07, 
153.84, 192.55, 194.07. Found, %: C, 67.01; H, 4.54; N, 4.99. M 271.27. C15H13NO4. Calculated, 
%: 66.41; H 4.83; N, 5.16. 
 
2.1.2. (3a) 3-methoxymethyl-5-(naphthalen-2-yl)-4-nitroso-1H-pyrazole 
Dissolve 0.5 g (1.85 mmol) of isonitrosodiketone 2a in 40 ml of ethanol. Hydrazine hydrate 
0.4 g (8 mmol) was added dropwise to the resulting mixture by continuously mixing. The progress 
of the reaction was monitored by TLC (thin layer chromatography) and the stirring was stopped 
when the starting compound was completely reacted. Diluted with water, filtered. Crystals of green 
color were obtained. Yield 0.15 g (30.36%), green crystals m.p. 125-126 °C. UV spectrum, λmax, nm 
(ε): 686 (63.2). Mass spectrum, m/z (I, %): 267 (95.10) [M]+, 153 (100), 127 (53), 45 (29). NMR 
Spectrum (1H, δ, ppm): 3.4 s (3H, СН3), 4.43 s (2H, СН2O), 7.61-8.35 m (7Н naphthyl), 8.89 s (1H, 
NH). NMR spectrum 13C, δ, ppm: 48.88 57.97, 66.91, 125.93, 127.19, 128.02, 128.76, 129.00, 
133.08, 133.79. Found, %: С 67.28; H 4.65; N 15.38. М 267.28. С15H13N3O2. Calculated, %: С 
67.40; H 4.90; N 15.72. 
 
2.1.3. (4a) 4-Amino-3-methoxymethyl-5-(naphthalen-2-yl)-1H-pyrazole 
0.075 g (0.28 mmol) of nitrosopyrazole 3a in methylene chloride (5 ml) was dissolved. 
Catalyst (Pd\C) (0.015 g) was added with vigorous stirring, 0.11 g (2.18 mmol) of hydrazine hy-
drate was added into the reaction mixture. The reaction was monitored by TLC. After 12 hours, the 
mixture was filtered off and evaporated. Colorless crystals were isolated. Yield 0.056 g (78.5%), 
m.p. 118-120 °C. UV spectrum, λmax, nm (ε): 303 (8680). Mass spectrum, m/z (Irel, %): 253 (100) 
[M]+, 222 (19), 192 (75), 154 (37), 127 (29) 45 (17). 1H NMR Spectrum (DMSO-d6), δ, ppm: 3.29 s 
(3H, СН3), 4.07 s (2Н, СН2О), 4.44 s (2H, NH2), 7.48-8.31 m (7Н naphthyl), 12.61 s (1H, NH). 
NMR spectrum 13C, δ, ppm: 57.28, 123.23, 123.87, 125.14, 125.88, 126.80, 127.80, 128.15, 131.85, 
133.53. Found, %: С 70.6; H 5.47; N 16.45. М 253.30. Calculated, %: С15H15N3O. С 71.13; Н 5.97; 
N 16.59. 
 
2.1.4. (5a) N-[1-Acetyl-3-(methoxymethyl)-5-(naphthalen-2-yl)-1H-pyrazol-4-yl]acetamide 
0.1 g (0.4 mmol) of aminopyrazole 4a in toluene (60 ml) was dissolved. The mixture was 
heated with continuous stirring. After dissolving the substance, 1.04 g (10.2 mmol) of acetic anhy-
dride was added. The progress of the reaction was monitored by TLC. After completion of the reac-
tion, the mixture was washed with water and a solution of diluted sodium carbonate. Colorless crys-
tals were isolated. M.p.: 193-195 °C. Yield 0.153 g (35%). IR spectrum (thin layer), ν, cm−1: 
1654.48, 1740.30 (С=O). 1H NMR Spectrum (DMSO-d6), δ, ppm: 2.09 s (3H, NHCOCH3), 2.76 s 
(3H, NCOCH3), 3.27 s (3H, СН3ОСН2), 4.61 s (2Н, СН3ОСН2), 7.58-8.31 m (7Н naphthyl), 9.73 s 
(1H, NH). 13C NMR spectrum (DMSO-d6), δ, ppm: 22.91, 23.10, 58.07, 62.95, 122.08, 124.82, 
126.53, 126.95, 127.15, 127.92, 128.50, 128.63, 128.75, 133.02, 133.24, 149.27, 170.10, 170.80. 
 
2.1.5. (5b) N-[1-Acetyl-3-(methoxymethyl)-5-phenyl-1H-pyrazol-4-yl]acetamide 
0.1 g (0.5 mmol) of aminopyrazole 4b in toluene (70 ml) was dissolved. The mixture was 
heated with continuous stirring. After dissolving the substance, 1 g (2 mmol) of acetic anhydride 
was added. The progress of the reaction was monitored by TLC. After completion of the reaction, 
the mixture was washed with water and solution of diluted sodium carbonate. Colorless crystals 
were isolated. M.p. 162-163 °C. Yield 0.055 g (38%). IR spectrum (thin layer), ν, cm−1: 1690, 1750 
(С=O). 1H NMR Spectrum (DMSO-d6), δ, ppm: 2.04 s (3H, NHCOCH3), 2.70 s (3H, NCOCH3), 
3.24 s (3H, СН3ОСН2), 4.56 s (2Н, СН3ОСН2), 7.45-7.77 m (5Н phenyl), 9.64 s (1H, NH). NMR 
spectrum 13C, δ, ppm: 22.85, 23.03, 58.07, 62.88, 121.80, 127.24, 128.98, 129.38, 131.20, 138.97, 
149.55, 170.19, 170.81. 
 
2.1.6. (6a) N-[3-(methoxymethyl)-5-(naphthalen-2-yl)-1-chloroacetyl-1H-pyrazol-4-yl]-2-
chloroacetamide 
0.1 g (0.4 mmol) of aminopyrazole 4a was dissolved in minimum amount of toluene 
(70 ml), with heating and continuous stirring. After dissolving the amine, 0.113 g (1 mmol) of chlo-
roacetyl chloride and 0.7 g (8.86 mmol) of pyridine were added. After filtering and washing the 
precipitate with water and soda solution, white crystals were obtained. M.p. 176-178 °C. The yield 
of the product was 0.035 g (22%). IR spectrum (thin layer), ν, cm−1:  1679, 1756.64 (С=O). NMR 
Spectrum (1H, δ, ppm).: 3.29 s (3H, СН3), 4.36 s (2H, СН2O), 4.65 s (2Н, NHCOCH2Cl), 5.36 s 
(2Н, NCOCH2Cl), 7.59-8.35 m (7Н naphthyl), 10.23 s (1H, NH). NMR spectrum 
13C, δ, ppm: 
42.93, 44.22, 58.20, 62.65, 121.52, 124.75, 126.78, 127.03, 127.35, 127.96, 128.07, 128.61, 128.63, 
132.96, 133.41, 139.73, 149.71, 166.18, 166.77. 
 
2.1.7. (6b) N-[3-(methoxymethyl)-5-phenyl-1-(chloroacetyl)-1H-pyrazol-4-yl]-2-
chloroacetamide 
0.128 g (0.63 mmol) of aminopyrazole 4b in toluene (70 ml) was dissolved with heating. 
After complete dissolution, 0.09 g (0.7 mmol) of chloroacetyl chloride was added. 0.5 g (6.3 mmol) 
of pyridine was added for binding the liberated hydrogen chloride. The reaction was monitored by 
TLC. After completion of the reaction, the mixture was washed with water and 10% soda solution. 
It was extracted with ether. The ether layer was evaporated. As a result, white precipitate was 
formed. M.p. 144-145 °C. The yield of the product was 0.2 g (88%). IR spectrum (thin layer), ν, 
cm−1: 1670.83, 1748.47 (С=O). 1H NMR spectrum (DMSO-d6), δ, ppm: 3.27 s (3H, СН3), 4.32 s 
(2H, СН2О), 4.61 s (2Н, NHCOCH2Cl), 5.30 s (2Н, NCOCH2Cl), 7.48-7.80 m (5Н phenyl), 10.12 s 
(1H, NH). 13C NMR spectrum (DMSO-d6), δ, ppm: 42.83, 44.12, 58.20, 62.65, 121.33, 126.52, 
127.40, 129.02, 129.74, 130.60, 139.65, 150.10, 166.15, 166.75. 
 
2.2. Terms and conditions of 1H NMR, IR, UV and mass spectra 
All NMR data were collected in DMSO-d6 on Bruker Avance III 600 spectrometer system 
(14.1 T, Bruker) at 295 K. For proton NMR experiments single p/2-pulse was applied. For proton 
NMR analyses the relaxation delay were 3 s, 90 p/2-pulses of 13.7 μs, spectral width is 5071 Hz. 
Mass spectra were recorded on Finnigan MAT 8200 with double-focusing Nier-Johnson ge-
ometry and electron impact as ionization method. Range of recorded mass was set in the range of 5-
2000 amu. 
The reaction process and the purity of the compounds were monitored by TLC on Sorbfil 
plates of PTSX-AF-B (Russia) in ethyl acetate-toluene system (1:2), the spots were detected in ul-
traviolet light. UV spectra were recorded on HELIOS OMEGA spectrophotometer in ethanol. IR 
spectra were obtained on IR microscope SpecTRA TECH InspectIR based on the IR Fourier spec-
trophotometer Impact 400. Elemental analysis was performed on automatic CHNS analyzer EURO 
EA 3000 [23]. 
 
2.3. Quantum-chemical calculations 
Molecular structures of 4a, 4b, 5a, 5b, 6a and 6b compounds were designed with help of 
DFT method, using BP86 exchange-correlation functional [24,25], def2-SVP basis set of atomic 
orbitals [26,27], Grimme dispersion correction [28,29] and ORCA software package [30]. RI ap-
proximation [31-37] was also additionally used in the case of calculations of their IR-spectra. 
 
3. Results and discussion 
Diketone 1a was treated with sodium nitrite in acetic acid (Figure 1). As a result, isonitroso-
diketone 2a with methoxymethyl and 2-naphthyl substituents was first obtained. In the cyclization 
of isonitrosodiketone 2a with hydrazine hydrate in alcohol, the previously unknown 3-
methoxymethyl-5-(naphthalen-2-yl)-4-nitroso-1H-pyrazole 3a was isolated as the only product. The 
reduction of compound 3a was carried out in solution of methylene chloride with an excess of hy-
drazine hydrate in the presence of a catalyst of 0.5% Pd\C. At the end of the reaction, a new 4-
amino-3-methoxymethyl-5-(naphthalen-2-yl)-1H-pyrazole 4a was isolated. Dividing the signal of 
the proton of the pyrazole ring in the 1H NMR spectrum of compound 4a indicates that it exists as 
two tautomeric forms: 4-amino-3-methoxymethyl-5-(naphthalen-2-yl)-1H-pyrazole and 4-amino- 5-
methoxymethyl-3-(naphthalen-2-yl)-1H-pyrazole. 
The reaction of acylation of aminopyrazole 4a and 4-amino-3-methoxymethyl-5-phenyl-1H-
pyrazole 4b [21] with acetic anhydride and chloroacetyl chloride was carried out. Aminopyrazoles 
4a and 4b with acetic anhydride gave white crystals of diacetyl derivatives 5a and 5b (Figure 1). In 
reaction 4a and 4b with chloroacetyl chloride in toluene with addition of pyridine, bis chloroacetyl-
derivatives in both the amine and the nitrogen of the pyrazole ring were isolated. We have previ-
ously shown that the acylation of these aminopyrazoles with chloroacetyl chloride in benzene takes 
place only at the nitrogen atom of the amine [38], but in the presence of pyridine 6a and 6b bis 
(chloroacetyl) derivatives were obtained. 
It was expected that, because of the tautomerism of 4a and 4b compounds, their acylation 
would result in a mixture of products with different positions of the acyl group at the nitrogen atoms 
of the pyrazole ring. However, when analyzing 1H NMR data, it was found that the product of the 
acylation reaction is only one of the possible isomers. 
 
 
Ar = 2-Naphthyl (a), Ph (b) 
Figure 1. The synthesis of acylated substituted 4-aminopyrazoles 
 
Quantum-chemical calculations of 4a and 4b tautomers were carried out for estimation of 
the synthesis results. It was shown, that their total energies difference is equal only to 0.004 eV. 
This value is essentially lower than energy of thermal oscillations at room temperature and can be 
explained by insignificant structural changes at transition from one form to another one, concerning 
generally the orientation of aromatic and methoxymethyl substituents (Figure 2, Table 1). 
 
 Figure 2. Structural formulae of both tautomer forms of 4-Amino-3-methoxymethyl-5-(naphthalen-2-yl)-1H-pyrazole 
 
Table 1. The values of some dihedral angles of 4a and 4b structures 
Compound 4a  4b 
Tautomer 1 2  1 2 
OC1C2C3, degrees -44.3 -47.4  -45.0 -47.7 
C3C4C5C6, degrees -26.8 -24.7  -26.6 -23.9 
 
Therefore existence of 4a and 4b compounds in two forms simultaneously is expected. This 
fact is confirmed by bifurcation of proton signal of pyrazole cycle in NMR 1H spectrums of these 
structures (Figure 3). 
 
 
Figure 3. 1H NMR spectrum (DMSO-d6) of 4-amino-3-methoxymethyl-5-(2-naphthyl)-1H-pyrazole (4a) 
 
From this point of view, acylation of 4a and 4b compounds at both nitrogen atoms of pyra-
zole seems equiprobable. However, it was mentioned above, reaction product in every specific case 
represents not a mix, and only one of two possible isomers. It is confirmed by NMR 1H data (Figure 
4), where spectrum of 5b diacetyl derivative contains of singlets of one methylene group and three 
methyl groups, that indicates the absence of isomerism related to position of acetyl group. 
 
 Figure 4. 1H NMR spectrum (DMSO-d6) of N-[1-Acetyl-3-(methoxymethyl)-5-phenyl-1H-pyrazol-4-yl]acetamide (5b) 
 
For identification of these isomers the geometry optimization of 5a, 5b, 6a and 6b structures 
was performed for the cases when acetyl or, correspondingly, chloroacetyl groups were placed by 
the nitrogen atom, situated near to aromatic substituent (5a-1, 5b-1, 6a-1 and 6b-1), and the nitrogen 
atom, situated distantly (5a-2, 5b-2, 6a-2 and 6b-2). It was established that at least four possible 
conformers correspond to every compound (Figure 5). They differ by mutual orientation of sub-
stituents in pyrazole cycle (Figure 6, Table 2). 
 
 
Figure 5. Molecular structure of isomers and conformers of 5b and 6b compounds 
  
Figure 6. Structural formulae of isomers of 5b (R = H) and 6b (R = Cl) compounds 
 
Table 2. The values of dihedral angles of 6a and 6b structures and their total energies (ΔE) relative 
to the lowest energy state 
Compound 5a-1  5a-2 
Conformer 1 2 3 4  1 2 3 4 
O1C1N1N2, degrees -21.6 -178.9 179.0 24.0  -172.1 5.4 9.3 -172.2 
C4C3C2C5, degrees 118.1 130.7 127.2 -117.6  148.3 158.3 149.9 155.0 
C2C5N3H1, degrees -29.4 152.7 -26.4 140.0  -33.0 114.0 -33.0 136.0 
C5C6C7O2, degrees -156.6 43.1 -157.1 45.9  -109.9 -111.9 -113.0 -109.8 
ΔE, eV 0.017 0.002 0.006 0.007  0.000 0.014 0.009 0.003 
Compound 5b-1  5b-2 
Conformer 1 2 3 4  1 2 3 4 
O1C1N1N2, degrees -20.3 178.9 177.3 23.7  -172.2 5.3 8.7 -172.2 
C4C3C2C5, degrees 115.0 125.4 124.6 -115.7  148.4 159.8 150.4 155.7 
C2C5N3H1, degrees -27.3 152.3 -25.0 140.8  -32.2 110.3 -31.8 134.1 
C5C6C7O2, degrees -154.8 43.2 -157.1 45.5  -110.2 -112.1 -112.9 -109.7 
ΔE, eV 0.017 0.002 0.006 0.008  0.000 0.014 0.009 0.004 
Compound 6a-1  6a-2 
Conformer 1 2 3 4  1 2 3 4 
O1C1N1N2, degrees -29.2 -179.9 178.5 -33.0  -172.3 5.1 11.3 -172.1 
C4C3C2C5, degrees 128.6 132.9 129.6 129.0  150.7 157.1 152.7 154.1 
C2C5N3H1, degrees -27.2 153.2 -24.2 170.4  -30.9 96.7 -32.6 131.8 
C5C6C7O2, degrees -156.9 42.8 -158.3 -20.7  -110.0 -113.4 -116.6 -110.3 
ΔE, eV 0.015 0.002 0.006 0.010  0.000 0.015 0.010 0.004 
Compound 6b-1  6b-2 
Conformer 1 2 3 4  1 2 3 4 
O1C1N1N2, degrees -27.6 179.1 178.0 29.2  -172.2 1.3 10.8 -172.2 
C4C3C2C5, degrees 126.3 127.8 127.2 -114.9  151.9 -141.8 157.9 155.4 
C2C5N3H1, degrees -25.6 152.8 -22.6 140.7  -30.5 103.5 -34.6 130.7 
C5C6C7O2, degrees -159.5 43.1 -159.4 47.5  -110.0 -110.7 -116.7 -110.5 
ΔE, eV 0.017 0.002 0.006 0.006  0.000 0.016 0.010 0.004 
 
The similar conclusion, in toto, can be done at comparative analysis of absorption vibration 
spectra, received by experimentally and as a result of DFT simulations (Figure 7). Here the Lor-
entzian broadening of spectral lines was used for visualization of calculated spectra, where the spec-
tral width on 1/2 height was equal to 15 cm−1. The shift of calculated spectral lines along frequen-
cies axis was performed relative to intensive maximum in the region of 1800 cm−1 of experimental 
spectrum by multiplication onto correction factor, which was equal to 0.979, 0.980, 0.975, 0.977, 
0.975, 0.978, 0.973 and 0.976 in the set of 5a-1, 5a-2, 5b-1, 5b-2, 6a-1, 6a-2, 6b-1 и 6b-2 structures, 
correspondingly. It was shown, that in all cases the results received with help of DFT calculations 
repeats well the experimental values. However, the best agreement is observed in the case of 5a-2, 
5b-2, 6a-2 and 6b-2 compounds. This fact is also additional confirmation that acylation of 4a and 
4b structures at the nitrogen atom, situated further from aromatic substituent, is more probable than 
at the second one of pyrazole cycle. 
 
Figure 7. Experimental and DFT calculated IR-spectrums of 5a, 5b, 6a and 6b compounds 
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